Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ovarian Neoplasms

Free Subscription 22.02.2021 2 Am J Obstet Gynecol 2 BMC Cancer 3 Br J Cancer 2 Gynecol Oncol 1 Lancet Oncol 1 Obstet Gynecol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
   Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
   Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
   PubMed         Abstract available
   
   
2. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
   Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
   Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. ZHANG H, Zhang K, Xu Z, Chen Z, et al
   MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
   BMC Cancer. 2021;21:163.
   PubMed         Abstract available
   
   
4. GUO J, Satoh K, Tabata S, Mori M, et al
   Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells.
   BMC Cancer. 2021;21:174.
   PubMed         Abstract available
   
   

   
   Br J Cancer

5. SKOLD C, Bjorge T, Ekbom A, Engeland A, et al
   Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study.
   Br J Cancer. 2020 Apr 27. pii: 10.1038/s41416-020-0849.
   PubMed         Abstract available
   
   
6. BOCHNER F, Fellus-Alyagor L, Ketter D, Golani O, et al
   Bimodal magnetic resonance and optical imaging of extracellular matrix remodelling by orthotopic ovarian tumours.
   Br J Cancer. 2020 May 11. pii: 10.1038/s41416-020-0878.
   PubMed         Abstract available
   
   
7. METCALFE KA, Price MA, Mansfield C, Hallett DC, et al
   Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis.
   Br J Cancer. 2020;123:268-274.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

8. BAANDRUP L, Dehlendorff C, Hertzum-Larsen R, Hannibal CG, et al
   Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer The Extreme study.
   Gynecol Oncol. 2021 Feb 11. pii: S0090-8258(21)00102.
   PubMed         Abstract available
   
   
9. DAHM-KAHLER P, Holmberg E, Holtenman M, Radestad AF, et al
   Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study.
   Gynecol Oncol. 2021 Feb 10. pii: S0090-8258(21)00059.
   PubMed         Abstract available
   
   

   
   Lancet Oncol

10. MORGAN RD, McNeish IA, Cook AD, James EC, et al
    Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
    Lancet Oncol. 2021;22:277-288.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

11. NITECKI R, Woodard T, Rauh-Hain JA
    Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies.
    Obstet Gynecol. 2020 Nov 5. doi: 10.1097/AOG.0000000000004163.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: